| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 64.35× | 64.35× | 63.41× | 59.52× | 62.84× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 9.82× | 9.57× | 9.66× | 9.12× | 20.75× | ||
| 2.04× | 2.04× | 1.90× | 1.78× | 1.75× | ||
| 46.01× | 46.01× | 3.18× | 3.94× | −1.91× | ||
| 1.04× | 1.04× | 1.34× | 0.49× | 1.63× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 62.84 | 59.52 | 63.41 | 64.35 | 64.35 | |
| Working Capital Turnover | 20.75 | 9.12 | 9.66 | 9.57 | 9.82 | |
| Asset Turnover | 1.75 | 1.78 | 1.90 | 2.04 | 2.04 | |
| Cash Conversion (CFO/Net Income) | -1.91 | 3.94 | 3.18 | 46.01 | 46.01 | |
| CFO/EBITDA | 1.63 | 0.49 | 1.34 | 1.04 | 1.04 |